Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients

Hidetaka Sasaki, Miwa Takei, Makiko Kobayashi, Richard B Pollard, Fujio Suzuki

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The effect of glycyrrhizin (GR) on HIV replication in cultures of peripheral blood mononuclear cells (PBMC) from HIV-infected patients was investigated. After the depletion of CD8+ T cells, PBMC from HIV+ patients (patient PBMC) and PBMC from healthy donors (healthy PBMC) were cocultured in the presence or absence of GR (100 μg/ml) for 21 days. In cultures of 13 of 42 samples of patient PBMC (13/42, 31%), GR inhibited more than 90% of HIV replication. Among 42 samples of patient PBMC, 20 were identified to be infected with a non-syncytium-inducing variant of HIV (NSI-HIV), 15 with a syncytium-inducing variant of HIV (SI-HIV), and the remaining 7 were classified as cells infected with SI-HIV and/or NSI-HIV. GR inhibited more than 90% of HIV replication in cultures of 12 patient PBMC samples infected with NSI-HIV (12/20, 60%). In patient PBMC infected with SI-HIV, GR inhibited HIV replication in only 1 patient (1/15, 7%). In cultures of patient PBMC, GR induced the production of CC chemokine ligand (CCL)4 and CCL5 in a dose-dependent manner. When the assay was performed in PBMC cultures supplemented with a mixture of monoclonal antibodies for CCL4 and CCL5, no evidence of anti-HIV activity of GR was found. These results indicate that GR has the potential to inhibit NSI-HIV replication in patient PBMC cultures by inducing the production of β-chemokines.

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalPathobiology
Volume70
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Glycyrrhizic Acid
Glycyrrhiza
Blood Cells
Blood
HIV
Cell culture
CC Chemokines
Cell Culture Techniques
T-cells
Chemokines
Giant Cells
Assays

Keywords

  • β-Chemokines
  • Glycyrrhizin
  • HIV

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Biochemistry
  • Immunology and Allergy
  • Cell Biology

Cite this

Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. / Sasaki, Hidetaka; Takei, Miwa; Kobayashi, Makiko; Pollard, Richard B; Suzuki, Fujio.

In: Pathobiology, Vol. 70, No. 4, 2002, p. 229-236.

Research output: Contribution to journalArticle

@article{f95de1bb2d084091bf1a163ce199b89b,
title = "Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients",
abstract = "The effect of glycyrrhizin (GR) on HIV replication in cultures of peripheral blood mononuclear cells (PBMC) from HIV-infected patients was investigated. After the depletion of CD8+ T cells, PBMC from HIV+ patients (patient PBMC) and PBMC from healthy donors (healthy PBMC) were cocultured in the presence or absence of GR (100 μg/ml) for 21 days. In cultures of 13 of 42 samples of patient PBMC (13/42, 31{\%}), GR inhibited more than 90{\%} of HIV replication. Among 42 samples of patient PBMC, 20 were identified to be infected with a non-syncytium-inducing variant of HIV (NSI-HIV), 15 with a syncytium-inducing variant of HIV (SI-HIV), and the remaining 7 were classified as cells infected with SI-HIV and/or NSI-HIV. GR inhibited more than 90{\%} of HIV replication in cultures of 12 patient PBMC samples infected with NSI-HIV (12/20, 60{\%}). In patient PBMC infected with SI-HIV, GR inhibited HIV replication in only 1 patient (1/15, 7{\%}). In cultures of patient PBMC, GR induced the production of CC chemokine ligand (CCL)4 and CCL5 in a dose-dependent manner. When the assay was performed in PBMC cultures supplemented with a mixture of monoclonal antibodies for CCL4 and CCL5, no evidence of anti-HIV activity of GR was found. These results indicate that GR has the potential to inhibit NSI-HIV replication in patient PBMC cultures by inducing the production of β-chemokines.",
keywords = "β-Chemokines, Glycyrrhizin, HIV",
author = "Hidetaka Sasaki and Miwa Takei and Makiko Kobayashi and Pollard, {Richard B} and Fujio Suzuki",
year = "2002",
doi = "10.1159/000069334",
language = "English (US)",
volume = "70",
pages = "229--236",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients

AU - Sasaki, Hidetaka

AU - Takei, Miwa

AU - Kobayashi, Makiko

AU - Pollard, Richard B

AU - Suzuki, Fujio

PY - 2002

Y1 - 2002

N2 - The effect of glycyrrhizin (GR) on HIV replication in cultures of peripheral blood mononuclear cells (PBMC) from HIV-infected patients was investigated. After the depletion of CD8+ T cells, PBMC from HIV+ patients (patient PBMC) and PBMC from healthy donors (healthy PBMC) were cocultured in the presence or absence of GR (100 μg/ml) for 21 days. In cultures of 13 of 42 samples of patient PBMC (13/42, 31%), GR inhibited more than 90% of HIV replication. Among 42 samples of patient PBMC, 20 were identified to be infected with a non-syncytium-inducing variant of HIV (NSI-HIV), 15 with a syncytium-inducing variant of HIV (SI-HIV), and the remaining 7 were classified as cells infected with SI-HIV and/or NSI-HIV. GR inhibited more than 90% of HIV replication in cultures of 12 patient PBMC samples infected with NSI-HIV (12/20, 60%). In patient PBMC infected with SI-HIV, GR inhibited HIV replication in only 1 patient (1/15, 7%). In cultures of patient PBMC, GR induced the production of CC chemokine ligand (CCL)4 and CCL5 in a dose-dependent manner. When the assay was performed in PBMC cultures supplemented with a mixture of monoclonal antibodies for CCL4 and CCL5, no evidence of anti-HIV activity of GR was found. These results indicate that GR has the potential to inhibit NSI-HIV replication in patient PBMC cultures by inducing the production of β-chemokines.

AB - The effect of glycyrrhizin (GR) on HIV replication in cultures of peripheral blood mononuclear cells (PBMC) from HIV-infected patients was investigated. After the depletion of CD8+ T cells, PBMC from HIV+ patients (patient PBMC) and PBMC from healthy donors (healthy PBMC) were cocultured in the presence or absence of GR (100 μg/ml) for 21 days. In cultures of 13 of 42 samples of patient PBMC (13/42, 31%), GR inhibited more than 90% of HIV replication. Among 42 samples of patient PBMC, 20 were identified to be infected with a non-syncytium-inducing variant of HIV (NSI-HIV), 15 with a syncytium-inducing variant of HIV (SI-HIV), and the remaining 7 were classified as cells infected with SI-HIV and/or NSI-HIV. GR inhibited more than 90% of HIV replication in cultures of 12 patient PBMC samples infected with NSI-HIV (12/20, 60%). In patient PBMC infected with SI-HIV, GR inhibited HIV replication in only 1 patient (1/15, 7%). In cultures of patient PBMC, GR induced the production of CC chemokine ligand (CCL)4 and CCL5 in a dose-dependent manner. When the assay was performed in PBMC cultures supplemented with a mixture of monoclonal antibodies for CCL4 and CCL5, no evidence of anti-HIV activity of GR was found. These results indicate that GR has the potential to inhibit NSI-HIV replication in patient PBMC cultures by inducing the production of β-chemokines.

KW - β-Chemokines

KW - Glycyrrhizin

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=0038649361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038649361&partnerID=8YFLogxK

U2 - 10.1159/000069334

DO - 10.1159/000069334

M3 - Article

C2 - 12679601

AN - SCOPUS:0038649361

VL - 70

SP - 229

EP - 236

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 4

ER -